InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.79+0.07 (+0.48%)
Close on Nov 16, 2026Market cap $294.58MP/E 36.1Yield –
InfuSystem profit margin
Profit margin (net margin) is net income as a percentage of revenue.
InfuSystem's profit margin for the twelve months ending Jun 30, 2026 was 6.0%. For fiscal 2025 it was 4.6%, against 1.7% the year before. The highest annual figure on record is 17.8% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.6% | +2.9 |
| FY2024 | Dec 31, 2024 | 1.7% | +1.0 |
| FY2023 | Dec 31, 2023 | 0.7% | +0.7 |
| FY2022 | Dec 31, 2022 | 0.0% | −1.4 |
| FY2021 | Dec 31, 2021 | 1.4% | −16.4 |
| FY2020 | Dec 31, 2020 | 17.8% | +16.1 |
| FY2019 | Dec 31, 2019 | 1.7% | +3.3 |
| FY2018 | Dec 31, 2018 | -1.6% | +27.5 |
| FY2017 | Dec 31, 2017 | -29.1% | −28.8 |
| FY2016 | Dec 31, 2016 | -0.3% | −4.3 |
| FY2015 | Dec 31, 2015 | 3.9% | −1.1 |
| FY2014 | Dec 31, 2014 | 5.0% | +2.4 |
| FY2013 | Dec 31, 2013 | 2.7% | +5.2 |
| FY2012 | Dec 31, 2012 | -2.5% | +80.6 |
| FY2011 | Dec 31, 2011 | -83.2% | −79.3 |
| FY2010 | Dec 31, 2010 | -3.9% | −5.9 |
| FY2009 | Dec 31, 2009 | 2.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 8.7% | +1.5 |
| Q1 FY2026 | Mar 31, 2026 | 3.0% | +3.8 |
| Q4 FY2025 | Dec 31, 2025 | 5.6% | +2.9 |
| Q3 FY2025 | Sep 30, 2025 | 6.2% | +1.1 |
| Q2 FY2025 | Jun 30, 2025 | 7.2% | +5.1 |
| Q1 FY2025 | Mar 31, 2025 | -0.8% | +2.7 |
| Q4 FY2024 | Dec 31, 2024 | 2.8% | +2.5 |
| Q3 FY2024 | Sep 30, 2024 | 5.1% | +3.0 |
| Q2 FY2024 | Jun 30, 2024 | 2.1% | +0.8 |
| Q1 FY2024 | Mar 31, 2024 | -3.5% | −2.4 |
| Q4 FY2023 | Dec 31, 2023 | 0.2% | −0.1 |
| Q3 FY2023 | Sep 30, 2023 | 2.2% | +0.5 |
| Q2 FY2023 | Jun 30, 2023 | 1.4% | +2.0 |
| Q1 FY2023 | Mar 31, 2023 | -1.1% | +0.3 |
| Q4 FY2022 | Dec 31, 2022 | 0.4% | −1.1 |
| Q3 FY2022 | Sep 30, 2022 | 1.6% | +3.3 |
| Q2 FY2022 | Jun 30, 2022 | -0.6% | −3.9 |
| Q1 FY2022 | Mar 31, 2022 | -1.4% | −4.1 |
| Q4 FY2021 | Dec 31, 2021 | 1.5% | −41.7 |
| Q3 FY2021 | Sep 30, 2021 | -1.7% | −13.4 |
| Q2 FY2021 | Jun 30, 2021 | 3.3% | −12.6 |
| Q1 FY2021 | Mar 31, 2021 | 2.7% | +4.6 |
| Q4 FY2020 | Dec 31, 2020 | 43.2% | +39.5 |
| Q3 FY2020 | Sep 30, 2020 | 11.7% | +6.4 |
| Q2 FY2020 | Jun 30, 2020 | 15.9% | +14.0 |
| Q1 FY2020 | Mar 31, 2020 | -1.9% | +3.3 |
| Q4 FY2019 | Dec 31, 2019 | 3.7% | +5.3 |
| Q3 FY2019 | Sep 30, 2019 | 5.3% | +8.4 |
| Q2 FY2019 | Jun 30, 2019 | 1.9% | +5.0 |
| Q1 FY2019 | Mar 31, 2019 | -5.3% | −6.5 |
| Q4 FY2018 | Dec 31, 2018 | -1.6% | +93.7 |
| Q3 FY2018 | Sep 30, 2018 | -3.1% | −2.4 |
| Q2 FY2018 | Jun 30, 2018 | -3.1% | +3.5 |
| Q1 FY2018 | Mar 31, 2018 | 1.2% | +9.6 |
| Q4 FY2017 | Dec 31, 2017 | -95.2% | −92.4 |
| Q3 FY2017 | Sep 30, 2017 | -0.7% | −1.1 |
| Q2 FY2017 | Jun 30, 2017 | -6.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -8.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -2.8% | – |
| Q3 FY2016 | Sep 30, 2016 | 0.3% | – |
See a number that looks wrong?